Trials
Vaccine pandemic preparedness through Airway Immunology Characterization: A collaboration between the Novo-Nordisk Foundation and independent academic researchers. In this study, we will carry-out in-deepth characterization of the immunological differences in cellular and humoral responses following influenza vaccination administered either nasal or intramuscular routes in healthy individuals aged 18-49 years. Furthermore, we aim to identify immunological […]
The aim of this study is to determine if a time-updated, eosinophil-guided inhaled corticosteroid treatment in patients with severe and very severe COPD can lead to non-inferior treatment responses to standard treatment with combined ICS, LAMA and LABA, and whether the side-effects of ICS can be reduced by this guided administration. COPD: Eosinophil-guidedReduction of Inhaled([…)
The main objective of this intervention is to determine whether evening administration of Long-acting muscarinic antagonists, as opposed to morning administration, is superior with respect to occurrence of hospitalization requiring AECOPD or death from all causes
For information on collaborative investigator trials and cohorts, please visit CHIP (INSIGHT) or INSIGHT